NST Stock Overview
Engages in the manufacture, distribution, and sale of mobile telemedical solution under the Pregnabit brand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Nestmedic S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.58 |
| 52 Week High | zł1.44 |
| 52 Week Low | zł0.50 |
| Beta | -0.040 |
| 11 Month Change | 4.32% |
| 3 Month Change | -13.43% |
| 1 Year Change | -56.72% |
| 33 Year Change | -53.60% |
| 5 Year Change | -35.84% |
| Change since IPO | -96.25% |
Recent News & Updates
Shareholder Returns
| NST | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | -0.2% |
| 1Y | -56.7% | -16.0% | 0.3% |
Return vs Industry: NST underperformed the Polish Medical Equipment industry which returned -16% over the past year.
Return vs Market: NST underperformed the Polish Market which returned 0.3% over the past year.
Price Volatility
| NST volatility | |
|---|---|
| NST Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.4% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: NST has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: NST's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 6 | Jacek Gnich | www.nestmedic.com |
Nestmedic S.A., together with its subsidiaries, engages in the manufacture, distribution, and sale of mobile telemedical solution under the Pregnabit brand. The company offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. It also provides Pregnabit Cloud, a software as a service system designed to work with telemedical cardiotocography examination devices implementing the required communication protocol to send measurement data during an examination; and PregnaView, a component of the Pregnabit system that functions as a separate medical device.
Nestmedic S.A. Fundamentals Summary
| NST fundamental statistics | |
|---|---|
| Market cap | zł17.13m |
| Earnings (TTM) | -zł5.79m |
| Revenue (TTM) | zł669.69k |
25.6x
P/S Ratio-3.0x
P/E RatioIs NST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NST income statement (TTM) | |
|---|---|
| Revenue | zł669.69k |
| Cost of Revenue | zł196.27k |
| Gross Profit | zł473.42k |
| Other Expenses | zł6.26m |
| Earnings | -zł5.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 70.69% |
| Net Profit Margin | -864.75% |
| Debt/Equity Ratio | 135.4% |
How did NST perform over the long term?
See historical performance and comparison